Back
NeoGenomics Vs. Panbela Therapeutics Industry Stock Comparison
Sell
41
NEO
NeoGenomics
Last Price:
13.69
Seasonality Move:
2.4%
Sell
11
PBLA
Panbela Therapeutics
Last Price:
0.52
Seasonality Move:
-24.2%
Sell
41
NeoGenomics (NEO)
is a Sell
Is NeoGenomics a Buy, Sell or Hold?
- The current NeoGenomics [NEO] share price is $13.68. The Score for NEO is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
- NEO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
11
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy, Sell or Hold?
- The current Panbela Therapeutics [PBLA] share price is $0.52. The Score for PBLA is 11, which is 78% below its historic median score of 50, and infers higher risk than normal.
- PBLA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
NEO Stock Price Chart
What is NeoGenomics's stock price today?
-
The NeoGenomics share price today is $13.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NEO is experiencing selling pressure, which indicates risk of future bearish movement.
PBLA Stock Price Chart
What is Panbela Therapeutics's stock price today?
-
The Panbela Therapeutics share price today is $0.52
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBLA is experiencing slight buying pressure.
NEO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.39 | Sell |
Relative Strength Index (14 RSI): | 35.42 | Sell |
Chaikin Money Flow: | -395339 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.28 - 15.36) | Sell |
Bollinger Bands (100): | (14.43 - 18.05) | Sell |
PBLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 32.23 | Sell |
Chaikin Money Flow: | 5599 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.54 - 0.64) | Sell |
Bollinger Bands (100): | (-0.9 - 12.68) | Sell |
NEO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.3 | Sell |
20-day SMA: | 14.81 | Sell |
50-day SMA: | 15.12 | Sell |
200-day SMA: | 15.49 | Sell |
8-day EMA: | 14.18 | Sell |
20-day EMA: | 14.63 | Sell |
50-day EMA: | 15.13 | Sell |
200-day EMA: | 15.48 | Sell |
PBLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.54 | Sell |
20-day SMA: | 0.59 | Sell |
50-day SMA: | 0.85 | Sell |
200-day SMA: | 16.66 | Sell |
8-day EMA: | 0.55 | Sell |
20-day EMA: | 0.63 | Sell |
50-day EMA: | 2.05 | Sell |
200-day EMA: | 814.76 | Sell |
NeoGenomics Earnings Growth & NEO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.20 per share, and an increase next year of $0.12 per share.
Panbela Therapeutics Earnings Growth & PBLA Earnings Dates
- Analysts estimate an earnings increase this quarter of $39.91 per share, a decrease next quarter of $0.00 per share, an increase this year of $2,223.30 per share, and a decrease next year of $0.36 per share.
NeoGenomics Technical Analysis
Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Panbela Therapeutics Technical Analysis
Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |